ICON Gross Profit 2010-2024 | ICLR
ICON annual/quarterly gross profit history and growth rate from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- ICON gross profit for the quarter ending September 30, 2024 was $0.591B, a 2.4% decline year-over-year.
- ICON gross profit for the twelve months ending September 30, 2024 was $2.458B, a 4.09% increase year-over-year.
- ICON annual gross profit for 2023 was $2.4B, a 8.39% increase from 2022.
- ICON annual gross profit for 2022 was $2.214B, a 46.82% increase from 2021.
- ICON annual gross profit for 2021 was $1.508B, a 84.51% increase from 2020.
| ICON Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2023 | $2,400 |
| 2022 | $2,214 |
| 2021 | $1,508 |
| 2020 | $817 |
| 2019 | $832 |
| 2018 | $778 |
| 2017 | $731 |
| 2016 | $705 |
| 2015 | $666 |
| 2014 | $600 |
| 2013 | $491 |
| 2012 | $397 |
| 2011 | $334 |
| 2010 | $359 |
| 2009 | $380 |
| ICON Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2024-09-30 | $591 |
| 2024-06-30 | $627 |
| 2024-03-31 | $619 |
| 2023-12-31 | $621 |
| 2023-09-30 | $606 |
| 2023-06-30 | $591 |
| 2023-03-31 | $583 |
| 2022-12-31 | $581 |
| 2022-09-30 | $567 |
| 2022-06-30 | $543 |
| 2022-03-31 | $523 |
| 2021-12-31 | $528 |
| 2021-09-30 | $508 |
| 2021-06-30 | $240 |
| 2021-03-31 | $232 |
| 2020-12-31 | $225 |
| 2020-09-30 | $208 |
| 2020-06-30 | $174 |
| 2020-03-31 | $210 |
| 2019-12-31 | $217 |
| 2019-09-30 | $211 |
| 2019-06-30 | $204 |
| 2019-03-31 | $199 |
| 2018-12-31 | $200 |
| 2018-09-30 | $196 |
| 2018-06-30 | $192 |
| 2018-03-31 | $190 |
| 2017-12-31 | $188 |
| 2017-09-30 | $181 |
| 2017-06-30 | $181 |
| 2017-03-31 | $181 |
| 2016-12-31 | $184 |
| 2016-09-30 | $177 |
| 2016-06-30 | $173 |
| 2016-03-31 | $172 |
| 2015-12-31 | $174 |
| 2015-09-30 | $168 |
| 2015-06-30 | $164 |
| 2015-03-31 | $160 |
| 2014-12-31 | $160 |
| 2014-09-30 | $158 |
| 2014-06-30 | $149 |
| 2014-03-31 | $133 |
| 2013-12-31 | $130 |
| 2013-09-30 | $126 |
| 2013-06-30 | $120 |
| 2013-03-31 | $217 |
| 2012-12-31 | $108 |
| 2012-09-30 | $102 |
| 2012-06-30 | $97 |
| 2012-03-31 | $181 |
| 2011-12-31 | $84 |
| 2011-09-30 | $82 |
| 2011-06-30 | $82 |
| 2011-03-31 | $161 |
| 2010-12-31 | $92 |
| 2010-09-30 | $86 |
| 2010-06-30 | $93 |
| 2010-03-31 | $178 |
| 2009-12-31 | $96 |
| 2009-09-30 | $93 |
| 2009-06-30 | $95 |
| 2009-03-31 | $96 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $18.679B | $8.120B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $96.890B | 12.02 |
| Cencora (COR) | United States | $46.107B | 17.62 |
| DiDi Global (DIDIY) | China | $23.233B | 0.00 |
| Revvity (RVTY) | United States | $15.535B | 26.63 |
| Avantor (AVTR) | United States | $15.498B | 23.24 |
| Natera (NTRA) | United States | $15.385B | 0.00 |
| Viatris (VTRS) | United States | $13.858B | 4.22 |
| BioMerieux (BMXMF) | France | $13.601B | 0.00 |
| Solventum (SOLV) | United States | $12.636B | 0.00 |
| CochLear (CHEOY) | Australia | $12.565B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.202B | 28.74 |
| Charles River Laboratories (CRL) | United States | $9.742B | 18.41 |
| Sonic Healthcare (SKHHY) | Australia | $8.273B | 0.00 |
| HealthEquity (HQY) | United States | $7.792B | 42.29 |
| Doximity (DOCS) | United States | $7.787B | 49.34 |
| Bausch + Lomb (BLCO) | Canada | $6.975B | 32.47 |
| Life Times (LTH) | United States | $4.762B | 31.52 |
| PACS (PACS) | United States | $4.502B | 0.00 |
| Sotera Health (SHC) | United States | $4.367B | 23.36 |
| Organon (OGN) | United States | $4.239B | 4.28 |
| Surgery Partners (SGRY) | United States | $3.778B | 41.86 |
| BrightSpring Health Services (BTSG) | United States | $3.070B | 65.30 |
| Ardent Health Partners (ARDT) | United States | $2.577B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.546B | 0.00 |
| Concentras Parent (CON) | United States | $2.480B | 0.00 |
| Premier (PINC) | United States | $2.271B | 11.34 |
| GoodRx Holdings (GDRX) | United States | $2.254B | 84.86 |
| GeneDx Holdings (WGS) | United States | $2.057B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.575B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.507B | 7.57 |
| Progyny (PGNY) | United States | $1.425B | 25.06 |
| Establishment Labs Holdings (ESTA) | $1.338B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.319B | 12.91 |
| CareDx (CDNA) | United States | $1.228B | 0.00 |
| Agilon Health (AGL) | United States | $1.123B | 0.00 |
| Embecta (EMBC) | United States | $0.864B | 5.76 |
| InnovAge Holding (INNV) | United States | $0.822B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| SBC Medicals (SBC) | United States | $0.722B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.488B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.483B | 0.00 |
| Enhabit (EHAB) | United States | $0.382B | 33.04 |
| DocGo (DCGO) | United States | $0.355B | 13.35 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.309B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.255B | 0.00 |
| ModivCare (MODV) | United States | $0.232B | 7.37 |
| Beauty Health (SKIN) | United States | $0.211B | 0.00 |
| Biodesix (BDSX) | United States | $0.195B | 0.00 |
| LifeMD (LFMD) | United States | $0.192B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.178B | 0.00 |
| MultiPlan (MPLN) | United States | $0.136B | 0.00 |
| Nutex Health (NUTX) | United States | $0.127B | 0.00 |
| So-Young (SY) | China | $0.092B | 22.35 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.059B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.057B | 0.00 |
| OncoCyte (OCX) | United States | $0.049B | 0.00 |
| NeueHealth (NEUE) | United States | $0.041B | 1.63 |
| Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.036B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| Oncology Institute (TOI) | United States | $0.021B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| KindlyMD (KDLY) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |